Pharmacometabolomics is a subset of metabolomics, which is the science of quantifying and analyzing the metabolites found in biological samples. Pharmacometabolomics, which is rapidly gaining popularity, has already started to blossom in the sectors of drug development and personalised medicine, where it is already assisting in the development of major insights and the advancement of knowledge and product offerings in these fields. Pharmacometabolomics is a subset of metabolomics that focuses on analyzing metabolites to determine how individuals respond to therapy. Pharmacometabolomics can assist in identifying individuals or groups of persons who are most likely to respond to treatments. It can also help to identify those who are at risk of experiencing adverse side effects
Title : Precision Pharmacotherapy in the Treatment of Epilepsy - Use of Antiseizure Medications and Therapeutic Blood Level Monitoring
Roy Gary Beran, University of New South Wales, Australia
Title : When something comes on time, it is education, if too late, it is therapy. Health or disease - It is our choice
Ewa Danuta Bialek, Institute of Psychosynthesis, Poland
Title : Antibody-Proteases as translational tools of the newest generation to be applied for biodesign and bioengineering to get Precision and Personalized healthcare services Re-armed
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : Exposome for precision medicine
Styliani Geronikolou, University Research Institute of Maternal and Child health & Precision Medicine, Greece
Title : Precision Diagnostics and Medical Devices: Innovative Imaging Technologies for Lung Cancer Screening in Large Populations
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Use of indocyanine green fluorescence imaging in the extrahepatic biliary tract surgery
Orestis Ioannidis, Aristotle University of Thessaloniki, Greece